Chemerin levels were increased in the sera of patients with gastric cancer [6], adrenocortical carcinoma [7], early stage oral squamous cell carcinoma [8], non-small cell lung cancer (NSCLC) [9,10], colorectal cancer [11], and pancreatic cancer [12] compared with the respective healthy controls. The gene discussed is RARRES2; the disease is gastric cancer.